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Abstract
            Automatic mode switching (AMS) algorithms were designed to prevent tracking of atrial
tachyarrhythmias (ATA) or other rapidly occurring signals sensed by atrial channels, thereby
reducing the adverse hemodynamic and symptomatic consequences of a rapid ventricular
response. The inclusion of an AMS function in most dual chamber pacemaker now provides
optimal management of atrial arrhythmias and allows the benefit of atrioventricular synchrony to
be extended to a population with existing atrial fibrillation. Appropriate AMS depends on several
parameters: a) the programmed parameters; b) the characteristics of the arrhythmia; c) the
characteristics of the AMS algorithm. Three qualifying aspects constitute an AMS algorithm:
onset, AMS response, and resynchronization. Since AMS programs also provide data on the time
of onset and duration of AMS episodes, AMS data may be interpreted as a surrogate marker of
ATAs recurrence. Recently, stored electrograms corresponding to episodes of ATAs have been
introduced, thus clarifying the accuracy of AMS in detecting ATAs Clinically this information
may   be   used   to   assess   the   efficacy   of   an   antiarrhythmic   intervention   or   the   risk   of
thromboembolic events, and it may serve as a valuable research tool  for evaluating the natural
history and burden of ATAs. 
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               In   early   generation   of   dual-chamber   pacemakers   (PMs)   paroxysmal   atrial
tachyarrhythmias (ATAs) were considered a contraindication to pacing modes with atrial
tracking due to concerns of rapid ventricular tracking of atrial arrhythmias. Automatic mode
switching (AMS) was first introduced as a trademark in implantable devices in 1993. AMS
algorithms were designed to prevent tracking of ATAs or other rapidly occurring signals sensed
by atrial channels, thereby reducing the adverse hemodynamic and symptomatic consequences of
a rapid ventricular response1 (Figure 1). The inclusion of an AMS function in most dual chamber
PMs now provides optimal management of atrial arrhythmias and allows the benefit of
atrioventricular synchrony to be extended to a population with existing atrial fibrillation (AF).
The devices of the present generation, indicated in all patients with the brady-tachy syndrome,
should also be considered in patients with sinus node disease without paroxysmal AF, obstructive
hypertrophic cardiomyopathy, or any condition that predisposes patients to paroxysmal AF2.
Clinical studies have shown that the incidence of ATAs and AMS in patients with dual chamber
PMs is high3,4. Since AMS programs also provide data on the time of onset and duration of AMS
episodes, AMS data may be interpreted a surrogate marker of ATAs recurrence. Clinically this
information may be used to assess the efficacy of an antiarrhythmic intervention or the risk of
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 5(3): 186-196 (2005)Giuseppe Stabile, Antonio De Simone, Enrico Romano,                                            187
“Automatic Mode Switching in Atrial Fibrillation”
thromboembolic events, and it may serve as a valuable research tool  for evaluating the natural
history and burden of ATAs. This article analyzes AMS concepts with regard to their algorithms,
clinical impact and useful for ATA diagnosis in patients with permanent PMs.
Figure 1. In a patient with a paroxysmal atrial fibrillation the automatic mode switching (AMS)
entry stored intracardiac electrogram showed the activation of AMS algorithm.
Automatic mode switching algorithms. 
            An optimal AMS algorithm should provide a high sensitivity and specificity for the
detection of atrial arrhythmias, maintain atrioventricular synchrony, prevent the triggering of
atrial arrhythmias and facilitate rapid resumption  of atrioventricular synchrony when the
arrhythmia ceases. When it is instrumented on a high voltage antiarrhythmic device, two more
functions are required: the withholding of inappropriate ventricular therapies and the delivery of
atrial therapies. 
            Many algorithms have been used by different manufacturers, in recent years, and, of
course, the clinical behaviour differs according to the pacemaker models.
               Appropriate  AMS   depends   on  several  parameters   (Table):   a)   the  programmed
parameters; b) the characteristics of the arrhythmia; c) the characteristics of the AMS algorithm.
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Table 1. Parameters which influence an appropriate mode switching.
Characteristics Remarks
Characteristics of
arrhythmia
Atrial rate, coexisting atrial flutter,
atrial amplitude electrogram
Programmed
parameters
Atrial sensing, atrial post-ventricular
blanking period
Characteristics of
the AMS
algorithm
Accuracy 
Onset
AMS response
Resynchronization
            In order to avoid inappropriate AMS a customized optimal care of the patient would be
required, with a thorough knowledge of the arrhythmia history, of the atrial signal amplitude
(mostly during atrial arrhythmia) and of the required programming parameters (i.e. the atrial
post-ventricular blanking period) and the characteristics of the available AMS algorithms. Indeed
AMS failure may occur if the amplitude of the atrial electrogram is intermittently or consistently
too small to be sensed or if an atrial signal occurs systematically during the atrial blanking
period6. Appropriate programming of atrial sensitivity, and the avoidance of ventriculo-atrial
cross-talk, near and far field and other fake signals are essential for optimal AMS performance.
            Three qualifying aspects constitute an AMS algorithm7:
-Onset: it is worthwhile to characterize the speed of response of the algorithm at arrhythmia
onset. It can be expressed in time or number of cycles. Rapid response algorithms exhibit rate
instability  and   slow   response   algorithms   exhibit   long   delay  in   response,   hence   risk   of
atrioventricular dissociation. A fast AMS might be capable of preventing symptoms not only in
patients with underlying atrioventricular block, but also in those with intact atrioventricular
conduction, as it avoids high ventricular paced rates at the onset of the arrhythmia. 
-AMS response: this is the ability of the algorithm to obtain ventricular pacing rate regularization
during the period between the onset of AMS and the termination of atrial arrhythmia. In several
PMs models, after the mode switch event, a different base rate could be programmed in the
ventricle. This provides a programmable elevated pacing rate to compensate for the loss of atrial
transport during periods of ATA, while the device is in a non-tracking mode. Furthermore, it is
quite always possible to program a cross-sensor feature, switching from a non-rate-responsive
mode to a sensor mode or vice versa. 
-Resynchronization:  it is defined as the response to normal sinus rhythm resumption or
arrhythmia ending, thus the time latency or the number of beats needed to recover the
atrioventricular tracking functioning. 
            It is clear that speed of response and rate stability are two independent and, unfortunately,
competing parameters. Also the termination response is independent from the onset response, in
fact shorter reaction times of the algorithm might be used without an increased risk for
inappropriate termination of mode switch. Some AMS algorithms use the same onset criteria to
resynchronize   after   arrhythmia   termination,   whereas   others   use   slower   criteria   of
resynchronization to avoid intermittent AMS during short runs of arrhythmia. 
               The type of nontracking mode and the adequacy of ventricular rate during AMS
determine the clinical efficacy of AMS7. Either VVI or DDI mode is used. The VVI mode during
AMS has been described as VDI because the maintenance of atrial sensing allows the
perpetuation or termination of AMS. Obviously during AMS there is no AV synchrony and the
DDI mode is functionally equivalent to the VVI mode. The DDI mode offers the advantage of
atrial pacing as soon as ATA terminates even if criteria for detection of ATA termination by the
device have not yet been met, thus avoiding AV dissociation when a sinus pause occurs at ATA
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 5(3): 186-196 (2005)Giuseppe Stabile, Antonio De Simone, Enrico Romano,                                            189
“Automatic Mode Switching in Atrial Fibrillation”
termination. This may result in PM mediated tachycardia if retrograde conduction is present, may
provoke PM syndrome, and occasionally may reinduce ATA. On the other hand when AF is
undersensed during AMS, atrial pacing in the DDI destination mode may paradoxically
perpetuate AF8. A sudden rate drop at the start of AMS can cause symptoms and decrease cardiac
output7. Therefore, rate smoothing algorithms gradually decrease the ventricular rate from the
rate at the moment of AMS to the sensor rate or the lower rate. In patients with complete AV
block, AMS should be performed to a rate responsive mode, since otherwise pacing will be
performed at the lower rate limit for long periods. This may not be adequate during physical
activity9.
Accuracy of AMS algorithms. The accuracy of an algorithm of detecting an ATA may be
expressed in terms of sensitivity and specificity8. Sensitivity of an AMS algorithms refers to its
ability to detect AT, avoiding a false negative, whereas specificity refers to the absence of AMS
during sinus rhythm, avoiding a false positive response. Obviously the greater the sensitivity the
lower the specificity. In the clinical setting, arrhythmia related and sensing related issues affect
significantly the accuracy of AMS algorithms. Atrial undersensing is responsible for a reduced
sensitivity   of   ATA   detection.   Two   different   forms   of   atrial   undersensing   have   to   be
distinguished8. True atrial undersensing due to insufficient atrial signal amplitude, and functional
atrial undersensing due to the coincidence of an atrial signal of sufficient amplitude with an atrial
blanking time. The latter is predominantly encountered in atrial flutter. A high programmed atrial
sensitivity may cause atrial sensing of far-field signals or noise, whereas a low atrial sensitivity
can lead to undersensing during AF. Optimal programming of atrial sensitivity for AMS requires
three times the safety margin compared to two times for sinus P waves sensing10. Oversensing of
ventricular far-field signals (tail end of the QRS complex) represents the most common cause of
false positive mode switching (95%), whereas this was rarely (5%) caused by miopotentials. In
general, unipolar atrial sensing, paced QRS rhythms, longer dipole lengths, septal and low right
atrial implants may predispose to far-field R wave sensing. Any circumstance that prolongs the
QRS complex (e.g., flecainide, amiodarone, hyperkalemia) favours such ventriculatrial cross talk.
Less commonly, oversensing of atrial signals can occur within the atrioventricular interval8. 
Automatic mode switching algorithm features
             There are three main methods for a device to recognize an atrial arrhythmia7:
a) Widely used is a “rate cut-off” criterion: sensed atrial rate exceeding a programmable value
(for a defined period of time or cycles) will result in AMS. In the set of these “cut-off” based
algorithms   atrial  rate  is   continuously  monitored   by  increasing/decreasing  counters  or   by
consecutive rapid atrial events counters and, depending on the length of the current atrial
interval, AMS is activated when atrial rate exceeds the programmed cut-off criterion. Another
variety of this category is the ATA response implemented on the Insignia PM (Guidant Inc., St.
Paul, MN, USA). Atrial events above the ATA detection rate increment the detection counter,
whereas events below the ATA detection rate decrement the counter. Atrial tachyarrhythmia is
detected   when  the   counter   reaches   a  fixed   value.  Following  this,   AMS   occurs   over   a
programmable  time between 1 and 5 minutes, and ventricular rate  falls  back from  the
atrioventricular Wenckebach rate to the lower rate or the sensor driven rate. When ATA
terminates, the ATA detection counter will decrement with each atrial event below the ATA
detection rate. Resynchronization to sinus rhythm occurs when the counter drops from 8 to 0.
This device is relatively slow to activate AMS following the onset of ATA, but allows rate
smoothing to be effected so as to minimize the beat-to-beat change in pacing rate prior to AMS,
and on AMS termination before resynchronization to sinus tracking.
b) Similar high value have the algorithm using a “running average” rate. Such method uses a
“mean atrial rate” based on a moving value related to the duration of the prevailing sensed atrial
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cycle as a criterion to move towards AMS. AMS will occur when the “filtered” or “matched”
atrial interval shortens to a predetermined duration. A cut-off or critical value is anyhow defined
for the fulfilment of the detection criterion, but it doesn’t refer to the actual atrial interval. This
algorithm is used in the Medtronic Thera DR, Kappa 400 and Gem DR implantable defibrillator
and the St. Jude Medical families Affinity and Identity. Because the process is gradual, the
rapidity of AMS will depend not only on the atrial tachycardia detection rate or interval but also
on the pre-existing sinus rate. It is easier for the matched atrial interval to reach the tachycardia
detection interval when atrial tachycardia occurs in the setting of a higher resting sinus rate than
from a sinus bradycardia. This is because the matching atrial interval starts from a shorter
baseline duration on its gradual way to reach the tachycardia detection interval. 
            In both methods a beat per beat analysis of the atrial coupling is performed for an early
detection of the arrhythmia. Some systems are indeed designed to avoid mode switch during
atrial ectopic beats or short runs of atrial tachycardia. For example, the Identity (St. Jude
Medical, Sylmar, California, USA) pacemaker family uses a “running average” algorithm to
define the ATA detection. This filtered rate-based algorithm ensures that AMS event only
happens during sustained (although it could be a short one) supra ventricular tachycardia and that
the device does not change mode on a single premature atrial contraction.
c) A last method does exist, and shows how sensors can also be used to determine the
“physiological” rate of the patient and discriminate with an arrhythmic high rate,[e.g., Diamond/
Clarity (Vitatron BV, Dieren, the Netherlands), SmarTracking of Marathon, (Intermedics, Inc.)
and Neway DR (Sorin Biomedica, Saluggia, Italy)]; taking into account the fluctuation in sinus
rate, a physiological heart rate range based on the sensor indicated rate is used to define sinus
rhythm, and rates beyond the upper range will activate AMS. 
            For example, the Vitatron Diamond II and Clarity DR AMS is based on a beat-to-beat and
sudden onset criterion, independent of a cut-off rate. It detects atrial arrhythmias based on a
sudden onset criterion, rather than a critical cut-off rate. Whenever an atrial rate above 100
beats/min and in excess of 15 beats/min with respect to the baseline atrial rate is detected, the
AMS is activated. When atrial rhythm shows a sudden increase of at least 15 beats over the
current atrial rhythm, the arrhythmia is detected and the pacemaker immediately switches from
DDDR to DDIR mode, thus avoiding ventricular tracking of the high abnormal atrial rate. 
            In recent years complex algorithms have been introduced that may combine two or more
methods to fine tune the AMS response and to avoid rapid fluctuation in pacing rate. These
combinations of algorithms use additional criteria to distinguish between different types of atrial
arrhythmia   and  other   rhythms  and  are   mostly  a  prerogative  of   implantable  cardioverter
defibrillators or dedicated PMs. For example, a P to R relationship and a rate criterion are
implemented in the Medtronic AT500 to detect AF and atrial tachycardia.
               Another typical example is represented by the Phylos II DR Biotronik Inc. (Berlin,
Germany) PM that uses a “retriggerable” atrial refractory period algorithm to provide protection
against ATAs. This simple and rapid algorithm continuously extends the total atrial refractory
period (TARP) if the PM detects a P wave in the actual TARP (but outside the atrial blanking
period), and the atrioventricular interval is not initiated. This causes a DVIR functioning with
ventricular based timing. Instantaneous resynchronization occurs when an atrial event occurs
outside the TARP, or when the base lower rate is reached. This algorithm provides a sensitive
and fast reacting response to onset and termination of ATA, however, it has a low specificity and
may result in frequent switching pacing during noise and atrial ectopics. In addition, competitive
(asynchronous) atrial pacing occurs during tachycardia, and may paradoxically reinduce AF if AF
terminates spontaneously. In addition to this algorithm, a statistical “x of y” criterion is used for
detection of ATA. It is detected if a predefined number of atrial sensed intervals x-out-of-y
(where y is the length of the “moving” observation window) are shorter than the ATA detection
interval. Resynchronization to sinus rhythm occurs when eight consecutive atrial sensing events
are below the ATA detection rate or are paced. This “x of y” criteria provides a higher specificity
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compared to the first retriggerable refractory period method.
               Ela Medical (Montrouge, France) also introduced a particularly complex method of
“fallback” algorithm, based on a WARAD (Window of Atrial Rate Acceleration Detection), able
to prevent high frequency pacing in the ventricle, providing immediate response to pathological
rhythm, even in case of partial undersensing, with good sensitivity and specificity. It is based on
a double criterion: combines an initial upper rate switch at the onset of ATAs, followed by AMS
based on the detection of a sustained atrial rate above a preset ATA detection rate. The WARAD
varies and is calculated as a percentage of the preceding PP interval. At the onset, only events
outside the window will be sensed and ventricular pacing triggered. This results in a “temporary
mode switch”  When 28 of 32 or 36 of 64 consecutive beats above the atrial tachyarrhythmia
detection rate are detected, AMS will be initiated (this is called “permanent mode switch”). A
further refinement during AMS allows the pacer to function in the DDIR mode for spontaneous
ventricular rate less than 100 beats/min, and VVIR mode when this rate is greater than 100
beats/min to avoid atrial competitive pacing. Resynchronization to sinus rhythm occurs if 24
consecutive atrial cycles are less than 110 beats/min. This counter will be reset if premature beats
are sensed within this confirmation period until the 24 atrial/ventricular cycles less than 110
beats/min are satisfied. 
            Some dual chamber pacemakers offer two different AMS algorithms, one for detection of
ATA including AF and a supplemental algorithm for the detection of atrial flutter unrecognized
by the primary algorithm. 
            Patients with paroxysmal atrial flutter represent a challenge for AMS algorithms. In
several of these patients, a unique form of AMS failure (termed the ‘2:1 lock-in’ phenomenon)
can be observed 11. AMS failure may occur during atrial flutter when alternate flutter waves
coincide with the post-ventricular atrial blanking period (locked-in phenomenon). There are little
data about the incidence of atrial flutter underdetection by implanted devices with AMS since
pacemaker memory functions do not store undetected atrial flutter episodes in contrast to
inappropriate AMS. In addition to the mode switching function (atrial tachy response), the Pulsar
Max System (Guidant Inc., St. Paul, MN, USA) offers an “atrial flutter response” (AFR). This
algorithm starts another refractory period (“AFR window”) of 260 ms (equivalent to an atrial rate
of 230 beats/min) if atrial events are sensed within the PVARP. As long as an atrial rate > 230
beats/min is sensed, successive AFR windows start and ventricular pacing is performed
independently of atrial sensing, which effectively constitutes AMS to the VDIR mode. Therefore,
the AFR provides instantaneous AMS. However, if every second atrial flutter potential occurs
during the blanked portion of the PVARP, the AFR will not be able to detect the ATA and 2:1
tracking will persist. No data on the sensitivity and specificity of this ATA detection algorithm
has yet been published. 
            Selection of the suitable algorithm must be done on a case-by-cases basis, considering the
following advices based on comparisons and bench testings. Evaluation of AMS performance has
to consider the rate of failure of ATA detection (sensitivity) and of inappropriate AMS
(specificity), delay between ATA onset and AMS (AMS onset delay), time of pacing at the upper
tracking limit, rate during AMS, delay between sinus conversion and return to tracking mode
(AMS termination delay), and the number of switches back and forth during one episode (mode
oscillations)7. In general, a rate cut-off detection method of ATAs provides a rapid AMS onset
and resynchronization to sinus rhythm at the termination of ATAs, but may cause intermittent
oscillations between the atrial tracking and AMS mode. This can be minimized with a counter of
total number of high rate events before the AMS occurs. The use of a running average algorithm
results in more stable rate control during AMS by reducing the incidence of oscillations, but at
the expense of delayed AMS onset and resynchronization to sinus rhythm2. 
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Clinical implication. 
            Whereas clinical events  (death, stroke, haemorrhage, new or worsening heart failure,
etc.) are the type of endpoint of real interest in studies of management of AF, they have been
seldom used. The primary reason for not using these endpoints is that they occur with a very low
frequency, therefore very large numbers of subjects must be studied in order to show a significant
therapy-induced change. This last problem has led to the use of surrogate endpoints in studies to
test therapies for AF12. The most common used surrogate endpoint to measure rhythm control is
the time to first symptomatic recurrence of AF. Automatic mode switching algorithms, which
provide data on the time of onset and duration of AMS episodes (Figure 2), allow a more
accurate determination of the proportion of time a patient with AF is in AF and have led to the
concept of “AF burden” (Figure 3). Moreover, a substudy of a randomized controlled trial of
atrial- versus ventricular-based pacing demonstrated that ATA episodes, detected by these
algorithms, were associated with increased rates of death and nonfatal stroke13. In view of the
facts that AMS events are common, have clinical impact, and may be used to verify a therapeutic
strategy to control AF, of primary importance is the accuracy of these algorithm in the detection
of ATAs. Studies without intracardiac electrograms (EGM) data in PMs patients reported an
incidence of ATAs in about 50% of cases using PMs memory data3,4. Using conventional
diagnostic methods, such as ECG and 24-h Holter monitoring, the incidence of ATAs decreased
to 4%-20% in PMs patients14,15.  
Figure 2. A detail of automatic mode switching histogram of pacemaker St Jude Identity DR,
which give information on AMS number, duration and sensed atrial rate during the episodes. 
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Figure 3. A detail of automatic mode switching histogram of pacemaker St Jude Identity DR,
which give information on atrial tachycardia/atrial fibrillation burden trend.
            Without concomitant ECG or EGM, the sensitivity and the specificity of AMS-related
data (event counter, histograms, burden) was unclear. In 40 patients with tachycardia-bradycardia
syndrome and Medtronic Thera or Kappa 700 PMs underwent Holter monitoring16. Comparison
of Holter data with PM interrogation demonstrated that 53 (98.1%) of 54 ATA episodes resulted
in AMS. The sensitivity and specificity of AMS for the duration of ATAs were 98.1% and 100%,
respectively.   A   substudy13  of   the   Mode   Selection   Trial   (MOST)   compared   ambulatory
monitoring with different PMs atrial high rate episodes data in 47 patients. Five patients had
ATA seen on both PMs and ambulatory monitoring, 41 had no arrhythmias with either recording,
and one patient had a false positive atrial high rate episode: this gave a sensitivity of 100% and a
specificity of 97.6%. 
            Recently, stored EGMs corresponding to episodes of ATAs have been introduced, thus
clarifying the accuracy of AMS in detecting ATAs (Figure 4). Pollak et al17 analyzed ATAs
episodes in 56 patients with Medtronic Prodigy and Thera model in which some ATAs episodes
had a stored atrial EGM snapshot of the atrial tachyarrhythmias. EGM confirmation of ATA
correlated with increasing duration and rate of episodes. While only 18% of 44 episodes < 10
seconds in duration and 18% of 56 detected ATA episodes at rate < 250/min were confirmed to
be true ATA, atrial high rate episodes at rates > 250/min and > 5 min in duration were confirmed
to be true ATA by the stored EGM in 15 (88%) of 17 episodes, although specificity decreased
when the programmed atrial sensitivity was increased. Another parameter which affects the
specificity of AMS in detecting a true ATA episode is the contiguity, that is the probability of
occurrence of another AMS within 5 minutes before or after an AMS. In a study on 24 patients
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with sick sinus syndrome and paroxysmal AF, implanted with St Jude Identity DR PMs 250
AMS episodes were collected18. Intracardiac electrogram recordings were available in each
episode to distinguish true arrhythmias from unnecessary AMS. Using the composite criterion of
contiguity and length (> 1 min), compared with only the criteria of length, the specificity of AMS
was increased from 77.2% to 93.2%, at the cost of 11.9% loss of sensitivity.
Figure 4. Intracardiac electrograms stored at onset of automatic mode switching.
            
               Implantable devices as PMs or implantable cardioverter-defibrillators with atrial
electrograms provide continuous rhythm monitoring and may thus enhance the diagnostic
accuracy of detection of asymptomatic AF19. This has been suggested in the Automatic
Interpretation for Diagnostic Assistance (AIDA) trial, in which paroxysm of AF lasting more
than one minute were recorded by the devices in half of the patients, 58% of these were
completely asymptomatic3. Recently, in a prospective long-term follow-up study20 continuous
EGM monitoring by an implantable device (Medtronic AT 500) was used for up to 42 months
document recurrences of AF and the exact duration of arrhythmia-free intervals and AF episode
duration in 110 patients with a class I indication for physiologic pacing and a history of AF. The
study demonstrated that asymptomatic AF escaped documentation by ECG recording during
follow-up in 59% of patients, moreover 38% of AF recurrences lasting more than 48 h were
completely   asymptomatic.   The   underestimated   prevalence   of   recurrent   AF,   particularly
asymptomatic, has obvious clinical implications, the most of which is related to the need of
anticoagulation in patients with AF. 
            Another study21 evaluated the clinical benefits of PM (Selection, Vitatron) diagnostic
function (AF 1.0) in the management of 40 patients with AF and conventional pacing indications.
AF recurrences were recordered in 71% of the follow-ups with symptoms reported by patients in
only 16%. Thirty-nine percent of therapeutic changes based on conventional assessment were
confirmed by AF 1.0 data, and in 61% of instances, the initial changes were modified by AF 1.0.
The authors concluded that PM diagnostic functions offered a unique documentation of AF in
asymptomatic patients, and allowed therapeutic adjustments impossible otherwise. 
            Finally on clinical basis, the symptomatic benefit of AMS is related to improvement of
tachycardia related symptoms by avoiding a rapidly paced ventricular rate at the onset of an atrial
tachycardia. A randomized, crossover, prospective study1  compared three pacing modalities-
DDDR with mode switching (DM), DDDR with conventional upper rate behaviour (DR) and
VVIR (VR)-in patients with a history of ATAs, and to assessed the efficacy of six AMS
algorithms. Forty-eight patients with a history of ATAs and heart block had a DM pacemaker
implanted. Pacemakers were programmed to DM, DR and VR modes for 4 weeks each in a
randomized crossover design. All subjects used a patient-activated electrocardiographic (ECG)
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recorder throughout the study and additionally underwent ambulatory ECG monitoring and a
treadmill exercise test in each mode. They completed three symptom questionnaires at the end of
each pacing period. At the end of the study, patients chose their preferred pacing period. DM was
significantly better than VR mode objectively (exercise time DM 8.1 min, VR 7.0 min, p < 0.01)
and subjectively (perceived well-being DM 69, VR 51, p < 0.001; functional class DM 2.2, VR
2.5, p < 0.05; subjective symptom score DM 21.2, VR 26.8, p = 0.01). Patient-perceived well-
being was significantly better with DM than with DR mode (DM 69, DR 60, p = 0.02). DM
mode was the preferred pacing period (DM 51%, DR 14%, VR 14%). Early termination of
pacing because of adverse symptoms was requested by 33% of patients during VR, 19% during
DR but only 3% during DM mode. A higher proportion of patients with a fast mode-switching
device preferred DM mode (fast 55%, slow 49%), whereas no patients with a fast mode-
switching device chose VR as the preferred mode (fast 0%, slow 19%). In the subgroup of
patients who had had atrioventricular node ablation, DM was also preferred to VR mode (DM
53%, VR 27%). Overall, there were only two cases of inappropriate mode switching and one case
of inappropriate tracking of an ATA. Significantly, the authors concluded that DDDR PM with
mode switching is the pacing mode of choice of patients with paroxysmal ATAs. 
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